CYTX Financial Facts
Other income (expense), net: -696KCost of product revenues: 945K
See Full Income Statement
Total assets: 34.61M
Long-term deferred rent: -324K
See Full Balance Sheet
Cytori Therapeutics (CYTX) Earnings
|
Expand Research on CYTX
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -1.1% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
4/1/19 | Q418 | -$0.20 | -$0.30 | +$0.10 | $376K | $1.89M | N/A | Details | |||
11/14/18 | Q318 | -$0.27 | -$0.30 | +$0.03 | N/A | $1.89M | N/A | Details | |||
8/14/18 | Q218 | -$0.59 | -$0.45 | -$0.14 | N/A | $1.86M | N/A | Details | |||
5/10/18 | Q118 | -$0.07 | -$0.06 | -$0.01 | $1.6M | $2.74M | = | Details | |||
3/8/18 | Q417 | -$0.10 | -$0.06 | -$0.04 | $1.5M | $2.74M | = | Details | |||
11/9/17 | Q317 | -$0.14 | -$0.13 | -$0.01 | $1.8M | $2.5M | = | Details | |||
8/10/17 | Q217 | -$0.19 | -$0.21 | +$0.02 | $1.5M | $2.23M | = | Details | |||
5/11/17 | Q117 | -$0.26 | -$0.28 | +$0.02 | $1.6M | $2.57M | = | Details |